Consent Order and Claims

The permission the business runs on

Herbalife's U.S. network is compensated under rules the Federal Trade Commission wrote in 2016 and an injunction a California court entered in 1986. Both are still binding. Against them sit one live class action over whether distributors are employees and $260.2 million of tax assessments across Brazil, India and Mexico — no loss accrued on $243.6 million of that file, and a loss accrued only on a minority portion of the $16.6 million Brazilian federal withholding matter — and $150.8 million of letters of credit and surety bonds outstanding, about $110 million of it posted to keep the Brazilian cases in court.

What the Consent Order actually changed

The July 2016 Consent Order resolved a multi-year FTC investigation and cost $200 million in cash, paid through Herbalife International of America [1]. The money is long spent. The operating terms are permanent, and they apply to one market only.

Every U.S. Member must be categorised as either a preferred member — a customer who buys at a discount for household use and has no right to resell or build a team — or a distributor. Distributors may be paid on three things and nothing else: purchases by preferred members, demonstrated profitable retail sales to end-use customers, and their own personal consumption within allowable limits. Distributors must also meet conditions before signing a lease for their Herbalife business, including leases for Nutrition Clubs [2].

That third clause reaches into the measurement system itself. Outside the United States and China a Member accumulates Volume Points when they buy product from Herbalife. In the United States a Member receives no Volume Points for a transaction until the product is sold on to a customer at a profit and the sale is documented [3]. Because the same qualification thresholds would then mean something different in the United States than elsewhere, Herbalife applies a "requalification equalization factor" in the U.S. to bring its thresholds back into line with other markets [4]. The retention series examined in Sales Leader Turnover therefore carries a company-set adjustment in its largest single country, disclosed in one sentence and never quantified. That is what the retention series is worth as a measure of network health. Reported sales-leader retention has risen 2.4 points since the January 2021 cycle, to 70.3%, while the last time Herbalife quantified the effect of its lowered re-qualification thresholds the gap was 8.2 points — 68.9% reported against 60.7% adjusted — and every filing since FY2021 has said the lower-threshold method was extended to more markets without restating the adjustment. [5] [6]

Source: FY2025 Form 10-K, Item 1 Business — Marketing Plan and U.S. FTC Consent Order [7] [8]; Item 1A Risk Factors [9].

The last row is the only term in the order that sets a hard number, and it is the least discussed. If total eligible U.S. sales on which compensation may be paid falls below 80% of Herbalife's total U.S. sales in a year, compensation payable to distributors on eligible U.S. sales is capped at 41.75% of the Net Rewardable Sales amount as defined in the order [10]. Herbalife has never disclosed where the eligible-sales ratio sits. The phrase "eligible U.S. sales" appears in the corpus only inside the risk factor and the historical description of the settlement — there is no reported figure, no trend, and no statement that the threshold has or has not been approached in any year. For a business whose U.S. net sales were $1,006.4 million in 2025 [11], an undisclosed ratio governs the payout rate on a fifth of the company.

Supervision has stepped down. The Consent Order subjected Herbalife to audits by an independent compliance auditor for seven years; that term ended on 28 May 2024, though the FTC keeps the right to inspect records and request compliance reports [12]. The obligations themselves did not expire with the auditor. Herbalife's own summary is that compliance "has impacted, and may continue to impact, our business operations, including our net sales and profitability" [13].

Two pieces of that disclosure have since been retired. The $200 million payment and the full description of the settlement sat in the Contingencies note through the FY2023 10-K and appear in neither the FY2024 nor the FY2025 note [14]. So did the sentence acknowledging that "a number of our Members disagreed with our decision to enter into the Consent Order," which opened the same risk factor through FY2023 and was dropped from FY2024 onward [15]. Neither removal changes an obligation; both reduce what a new reader finds.

An older injunction, and the company's own precedent

A second order predates the FTC by thirty years. A permanent injunction entered in California in October 1986, settling an action brought by the state Attorney General, the State Health Director and the Santa Cruz County District Attorney, restricts advertising claims, prohibits certain recruiting-related investments from Members, and mandates that payments to Members be premised on retail value [16]. Forty years on it is still cited alongside the Consent Order as a live constraint on the compensation model.

Its aftermath is the clearest evidence in the filings for how a legal event reaches the network. Herbalife's own risk factor states that adverse publicity from the 1986 injunction "caused a rapid, substantial loss of Members in the United States and a corresponding reduction in sales beginning in 1985" [17]. The company's own account measures the cost of that episode in members and sales.

Management has referred to the 2016 order on an earnings call once in five years. Across the twenty indexed calls from the second quarter of 2021 to the first quarter of 2026, the phrase "Consent Order" does not appear at all and the FTC is named a single time — by John DeSimone, then President and now Chief Financial Officer, describing the senior distributor cohort as having "been very resilient to things like the implementation of the FTC order and other very unique — Herbalife unique and global situations that were challenging" [18]. That is management's position on the record: the rules were a shock the network absorbed. The words "misclassification," "independent contractor" and "class action" appear in none of the twenty calls.

The employment question

Among the unresolved legal matters, the one bearing most directly on the compensation model is a private suit rather than a regulatory action. On 31 October 2024 Herbalife and certain executive officers were named in a purported class action in Los Angeles County Superior Court, Sarah DeSimone v. Herbalife Ltd. et al., alleging violations of the California Labor Code including misclassification of distributors as independent contractors. An amended complaint filed on 21 February 2025 added claims under the California Private Attorneys General Act. Damages are unspecified; Herbalife says it cannot reasonably estimate a loss and does not believe one is probable, and nothing is accrued [19].

The claim runs at the joint of the model. Herbalife's Item 1 lists "classification by government agencies of our Members as employees of the Company" among the regulated conduct it faces in foreign markets, and notes it is subject in various markets to social-security assessments and severance obligations that constrain what rules and termination criteria it can impose on Members without incurring them [20]. The Consent Order risk factor makes the same point from the other side: Herbalife does not have the level of influence over Members it "would if they were our employees" [21]. The company relies on independent-contractor status both to avoid employment cost and to disclaim control over conduct — and California is the one jurisdiction where a court has been asked to test it. The case is at the pleading stage and no certification ruling is disclosed, so nothing here is quantifiable yet.

The tax file

Away from the network rules sits a payment exposure the balance sheet largely does not carry. At 31 March 2026 Herbalife disclosed $260.2 million of named, live tax assessments in three countries. No loss is accrued on $243.6 million of that file. The exception is the $16.6 million of Brazilian federal withholding assessments on payments to Members, where the company states it "has not accrued a loss for the majority of the assessments" — so a loss is accrued on a minority portion of that one matter [22].

Sources: Q1 FY2026 Form 10-Q, Note 5 Contingencies [23] [24] and Note 4 Long-Term Debt [25]; market value derived from 103,669,416 shares outstanding at 29 April 2026 [26] at the 27 July 2026 close of $12.18.

Source: Q1 FY2026 Form 10-Q, Note 5 Contingencies, Tax Matters, at the 31 March 2026 spot rate [27] [28].

The total is a floor rather than a ceiling. It excludes three Brazilian ICMS assessments appealed in 2015 whose amounts are not stated — only the $12.1 million of surety bonds posted against some of them — and it excludes the $13.6 million of Mexican VAT receivables whose refund the company says may be delayed [29]. It also excludes the São Paulo 2018 assessment of $44.1 million, which closed in Herbalife's favour in August 2025. The India component of $109.7 million is the same file examined in India Concentration; what the consolidated view adds is that India is 42% of a problem Herbalife has in three countries at once.

Holding the cases open costs balance-sheet capacity. At 31 March 2026 Herbalife had $150.8 million of issued but undrawn letters of credit and similar arrangements, of which roughly $45 million was an undrawn letter of credit issued against the revolving credit facility and roughly $65 million was surety bonds, both for the Brazil assessments; a further $15 million letter of credit obtained in November 2024 is fully cash-collateralised and does not consume revolver capacity [30], with $15.2 million of restricted cash sitting behind it [31]. Brazilian tax litigation therefore consumes about $45 million of the revolver that the minimum-liquidity covenant in Debt and Covenants measures against.

The accounting treatment is worth pinning precisely, because the two numbers measure different things and are often conflated. The unaccrued $243.6 million is assessments the company judges either not probable of loss or more likely than not to be won, so no liability is recorded under either loss-contingency or income-tax standards. Separately, Herbalife does carry a recognised balance for uncertain income-tax positions: $45.7 million including interest and penalties at 31 December 2025, against $51.3 million a year earlier and $67.4 million at the end of 2023 [32] [33].

Source: FY2025 Form 10-K, Note 12 Income Taxes, unrecognized tax benefits rollforward [34].

The recognised provision has fallen by a third in two years, driven by reductions for prior-year positions, audit settlements and expiring statutes of limitations [35]. The disclosed dispute file over the same period did not fall.

What has already cleared

The direction of travel on the federal overhang has been toward resolution, and it belongs in the same frame. The deferred prosecution agreement Herbalife entered with the Department of Justice in 2020 over FCPA books-and-records violations in China — the matter that cost $123 million in penalties, disgorgement and prejudgment interest in September 2020 [36] — was dismissed with prejudice in 2024 [37]. The independent compliance auditor's term under the Consent Order ended in May 2024 [38]. In Brazil the largest single assessment closed in the company's favour last August and the 2020 and 2021 years have won at first instance [39]. In India the two oldest income-tax years were won at tribunal [40].

The balance of the exposure

On the evidence, the residual legal exposure is weighted toward rule risk rather than payment risk. The $260.2 million assessment file is a fifth of the equity's market value, but it is slow, spread across three countries, contested at multiple levels, and winning more first-instance decisions than it is losing — and the recognised provision behind it has been falling, not building. The permanent constraints are the ones without a number attached: a compensation formula in the largest single country that Herbalife does not report against its own 80% trigger, a measurement basis that differs there from everywhere else and is reconciled by an undisclosed factor, and an independent-contractor status now under test in California. Herbalife's own filings supply the reason to weight those more heavily than the cash: the last time a court order reached this network, the company records that members left quickly and sales fell [41].

The strongest fact against that read is the United States itself. The Consent Order has governed U.S. compensation since 2016, the independent auditor has been and gone, and U.S. net sales were $1,006.4 million in 2025 against $1,026.0 million in 2024 — a 1.9% decline, in a market where prescription weight-loss drugs and retail protein are both fully present [42]. Ten years of the strictest rules in the network produced erosion, not the 1985 outcome, and the competing explanations examined in Weight Management and GLP-1 mean the rules cannot be assigned the decline on their own.

Three disclosures would move this. A ruling on class certification in DeSimone, which would convert an unquantifiable claim into a bounded one and is the single most likely source of a step-change. Any statement — in a 10-K risk factor or a court filing — locating the eligible-U.S.-sales ratio relative to the 80% trigger, which would tell a reader whether the 41.75% cap is theoretical or near. And an adverse judicial-level decision in São Paulo on the 2013 or 2014 years, the two already lost administratively and now backed by $65 million of bonds, which would convert posted collateral into cash paid and would test whether the remaining Brazilian years follow.